0
Skip to Content
ProEncia
Home
Patients
Pipeline
Technology
Approach
Team
About Us
News
Contact Us
ProEncia
Home
Patients
Pipeline
Technology
Approach
Team
About Us
News
Contact Us
Home
Patients
Folder: Science
Back
Pipeline
Technology
Approach
Folder: Company
Back
Team
About Us
News
Contact Us
ProEncia Biotechnology Closes Pre-Seed Funding to Advance Next-Gen, Patent-Pending Periodontal Disease Treatment
Austin L 5/19/26 Austin L 5/19/26

ProEncia Biotechnology Closes Pre-Seed Funding to Advance Next-Gen, Patent-Pending Periodontal Disease Treatment

Fast-growth biopharma startup develops groundbreaking product pipeline to target oral health epidemic

Read More

ProEncia

ProEncia’s products are currently under clinical investigation and are not approved by the FDA or any other regulatory agency for any use. The safety and efficacy of ProEncia products have not been established. Nothing on this website should be interpreted as a claim of safety or efficacy, a recommendation for use, or an offer to sell any product. This site is intended for informational purposes only and is not directed at patients seeking treatment.

Home

Team

Science

Contact Us

©2026 ProEncia Biotechnology Inc.
All rights reserved.